1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Cambodia and Laos Pharmaceuticals and Healthcare Report Q1 2016

Cambodia and Laos Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 74 pages

Includes 3 FREE quarterly updates

BMI View: While the underdeveloped nature of its pharmaceutical and health care sector will bring aboutcommercial benefits for foreign investors, competition from relatively low risk and higher rewards marketssuch as Vietnam means that Cambodia will remain low on investors'' priority list

Headline Expenditure Projections

- Pharmaceuticals: KHR9108bn (USD228mn) in 2014 to KHR1,0081bn (USD252mn) in 2015; +107%in local currency terms and US dollar terms Forecast remains unchanged from previous quarter

- Healthcare: KHR5,1198bn (USD13mn) in 2014 to KHR5,6762bn (USD14mn) in 2015; +109% inlocal currency terms and US dollar terms Forecast unchanged from previous quarter

Table Of Contents

Cambodia and Laos Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Cambodia 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Latest Trend 11
Structural Trends 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cambodia 2011-2019) 12
Healthcare Market Forecast 14
Structural Trends 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cambodia 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cambodia 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cambodia 2011-2019) 17
Pharmaceutical Trade Forecast 18
Structural Trends 18
Table: Pharmaceutical Trade Data And Forecasts (Cambodia 2013-2019) 19
Pharmaceuticals and Healthcare Risk/Reward Index 20
Asia Pacific Risk/Reward Index 20
Cambodia Risk/Reward Index 27
Rewards 27
Risks 27
Market Overview 29
Healthcare Sector 30
Health Insurance 31
Research and Development 32
Clinical Trials 33
Epidemiology 34
Regulatory Review 36
Regulatory Regime 36
Intellectual Property Issues 36
Counterfeit Medicines 37
Pricing And Reimbursement 39
Competitive Landscape 40
Pharmaceutical Sector 40
Company Developments 42
Table: Multinational Market Activity 42
Pharmaceutical Wholesale 43
Pharmaceutical Retail 43
Company Profile 45
Pfizer 45
PharmaProduct Manufacturing (PPM) 47
Sanofi 50
Demographic Forecast 53
Table: Population Headline Indicators (Cambodia 1990-2025) 54
Table: Key Population Ratios (Cambodia 1990-2025) 54
Table: Urban/Rural Population and Life Expectancy (Cambodia 1990-2025) 55
Table: Population By Age Group (Cambodia 1990-2025) 55
Table: Population By Age Group % (Cambodia 1990-2025) 56
Demographic Forecast 58
Table: Population Headline Indicators (Laos 1990-2025) 59
Table: Key Population Ratios (Laos 1990-2025) 59
Table: Urban/Rural Population and Life Expectancy (Laos 1990-2025) 60
Table: Population By Age Group (Laos 1990-2025) 60
Table: Population By Age Group % (Laos 1990-2025) 61
Demographic Forecast 63
Table: Population Headline Indicators (Myanmar 1990-2025) 64
Table: Key Population Ratios (Myanmar 1990-2025) 64
Table: Urban/Rural Population and Life Expectancy (Myanmar 1990-2025) 65
Table: Population By Age Group (Myanmar 1990-2025) 65
Table: Population By Age Group % (Myanmar 1990-2025) 66
Glossary 68
Methodology 70
Pharmaceutical Expenditure Forecast Model 70
Healthcare Expenditure Forecast Model 70
Notes On Methodology 71
Risk/Reward Index Methodology 72
Index Overview 73
Table: Pharmaceutical Risk/Reward Index Indicators 73
Indicator Weightings 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.